Search for human, veterinary and plants medications, drugs, supplements, herbal, nutritional and homoeopathic products;

prescription and over-the-counter medicines and medical devices;

beauty products and cosmetics, natural remedies and other pharmaceutical products

Stamibio Beauty - Dermocosmetic Anti-aging cream

Marketed by: GUNA
Active ingredient: ROE EXTRACT, BIO-PLEX RNA, OLIGOELEMENTI, JOJOBA OIL, RHODIOLA ROSEA, GINSENG, GUARANÀ, OENOTHERA BIENNIS, Coenzyme Q10 (Ubiquinone)
Other information: Cream

Available in: Italy
Language: English
Source: myHealthbox

Stamibio Lotion Dermocosmetic Restructuring Lotion

Marketed by: GUNA
Active ingredient: ROE EXTRACT, GINGKO BILOBA, SALVIA OFFICINALIS, VITAMIN E
Other information: Lotion

Available in: Italy
Language: English
Source: myHealthbox

Stamibio Calmderm Fluid dermocosmetic cream

Marketed by: GUNA
Active ingredient: ROE EXTRACT, GLYCYRRHETINIC ACID , VITAMIN E , PROVITAMIN D , BOSWELLIA SERRATA, LECITHIN, ZANTHALENE, CALMING AGENT (SYMSITIVE)
Other information: Cream

Available in: Italy
Language: English
Source: myHealthbox

Stamibio Derm Skin-protecting dermocosmetic cream

Marketed by: GUNA
Active ingredient: Roe extract, Glycyrrhetinic acid, Vitamin E (Tocopheryl acetate), 7-Dehydrocholesterol ,Boswellia serrata, Zanthoxylum alatum
Other information: Cream

Available in: Italy
Language: English
Source: myHealthbox

Stamibio Serum Dermocosmetic serum

Marketed by: GUNA
Active ingredient: ROE EXTRACT, HIGH MOLECULAR WEIGHT HYALURONIC ACID, INOSITOL, HOP EXTRACT, COCOA EXTRACT, GINSENG, GUARANÀ,LOTUS EXTRACT, HYDROLYZED DNA AND RNA, MACA EXTRACT, TRACE ELEMENTS, ANTI-SPOT COMPLEX
Other information: Serum

Available in: Italy
Language: English
Source: myHealthbox

Fluimucil 200 mg granules for oral solution

Marketed by: Zambon S.p.A.
Active ingredient: Acetylcysteine
Other information: Granules for oral solution - 200mg

Available in: Ireland
Language: English
Source: HPRA - Health Products Regulatory Authority - Ireland

Concerta XL 27 mg prolonged-release tablets

Marketed by: Imbat Limited
Active ingredient: Methylphenidate hydrochloride
Other information: Tablets - 27 mg

Available in: Ireland
Language: English
Source: myHealthbox

Concerta XL 36 mg prolonged-release tablets

Marketed by: Imbat Limited
Active ingredient: Methylphenidate hydrochloride
Other information: Tablets - 36 mg

Available in: Ireland
Language: English
Source: myHealthbox

Rasilez 150 mg film-coated tablets

Marketed by: Novartis Europharm Limited
Active ingredient: Aliskiren
Other information: Film-coated tablet - 150 mg

Available in: European Union
Language: English
Source: EMA - European Medicines Agency - Europe

Rasilez HCT 150 mg/12.5 mg film-coated tablets

Marketed by: Novartis Europharm Limited
Active ingredient: Aliskiren, Hydrochlorothiazide
Other information: Film-coated tablet - 150 mg aliskiren (as hemifumarate) and 12.5 mg hydrochlorothiazide

Available in: European Union
Language: English
Source: EMA - European Medicines Agency - Europe

Rasilez HCT 150 mg/25 mg film-coated tablets

Marketed by: Novartis Europharm Limited
Active ingredient: Aliskiren, Hydrochlorothiazide
Other information: Film-coated tablet - 150 mg aliskiren (as hemifumarate) and 25 mg hydrochlorothiazide

Available in: European Union
Language: English
Source: EMA - European Medicines Agency - Europe

Rasilez HCT 300 mg/12.5 mg film-coated tablets

Marketed by: Novartis Europharm Limited
Active ingredient: Aliskiren, Hydrochlorothiazide
Other information: Film-coated tablet - 300 mg aliskiren (as hemifumarate) and 12.5 mg hydrochlorothiazide

Available in: European Union
Language: English
Source: EMA - European Medicines Agency - Europe

Eliquis 2.5 mg film-coated tablets

Marketed by: Bristol-Myers Squibb, Pfizer EEIG
Active ingredient: Apixaban
Other information: Film-coated tablet - 2.5 mg

Available in: European Union
Language: English
Source: EMA - European Medicines Agency - Europe

Toujeo 300 units/ml solution for injection in a pre-filled pen

Marketed by: Sanofi-Aventis Deutschland GmbH
Active ingredient: Insulin glargine
Other information: Solution for injection - Each ml contains 300 units insulin glargine (equivalent to 10.91 mg). Each pen contains 1.5 ml of solution for injection, equiva

Available in: European Union
Language: English
Source: EMA - European Medicines Agency - Europe

Toujeo 100 units/ml solution for injection in a vial

Marketed by: Sanofi-Aventis Deutschland GmbH
Active ingredient: Insulin glargine
Other information: Solution for injection - Each ml contains 100 units insulin glargine* (equivalent to 3.64 mg). Each vial contains 5 ml of solution for injection, equival

Available in: European Union
Language: English
Source: EMA - European Medicines Agency - Europe

Toujeo 100 units/ml solution for injection in a cartridge

Marketed by: Sanofi-Aventis Deutschland GmbH
Active ingredient: Insulin glargine
Other information: Solution for injection - Each ml contains 100 units insulin glargine (equivalent to 3.64 mg). Each cartridge contains 3 ml of solution for injection, equ

Available in: European Union
Language: English
Source: EMA - European Medicines Agency - Europe

Toujeo 100 units/ml solution for injection in a cartridge for OptiClik

Marketed by: Sanofi-Aventis Deutschland GmbH
Active ingredient: Insulin glargine
Other information: Solution for injection - Each ml contains 100 units insulin glargine (equivalent to 3.64 mg). Each cartridge contains 3 ml of solution for injection, equ

Available in: European Union
Language: English
Source: EMA - European Medicines Agency - Europe

9-12-2015

Orphan designation: Imatinib mesilate, for the: Treatment of myelodysplastic / myeloproliferative diseases

On 23 December 2005, orphan designation (EU/3/05/340) was granted by the European Commission Novartis Europharm Limited, United Kingdom, for imatinib mesilate for the treatment of myelodysplastic / myeloproliferative diseases. Please note that this product...

Europe - EMA - European Medicines Agency

6-7-2015

CardioQH Ubiquinol (2015-06-15)

Canada - Health Canada

6-7-2015

Expanded recall: Dr. ColorChip recalls Automotive Touch-Up Paint and SealAct Blending Solution

Health Canada’s sampling and evaluation program has revealed that the products do not meet labelling requirements for consumer chemical products under the Canada Consumer Product Safety Act. ...

Canada - Health Canada

6-7-2015

Universal Connect Corp recalls Various Sens.us TABU Style Hair Products in Pressurized Containers

The recalled hair products do not meet labelling requirements for pressurized containers and potentially flammable products under the Cosmetics Regulations and Food and Drugs Act. This lack of labelling information, including lack of appropriate warnings, ...

Canada - Health Canada

4-7-2015

Scientific Opinion on the safety of UV-treated bread as a novel food EFSA Panel on Dietetic Products, Nutrition and Allergies

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA Panel) was asked to carry out the additional assessment for UV-treated br...

Europe - EFSA - European Food Safety Authority EFSA Journal

4-7-2015

Scientific Opinion on the substantiation of a health claim related to Symbiosal® and lowering of blood pressure and reduced risk of hypertension pursuant to Article 14 of Regulation (EC) No 1924/2006

EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) Following an application from Han-Asiabiotech GmbH, submitted for authorisation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006 via the Competent Authority of...

Europe - EFSA - European Food Safety Authority EFSA Journal

4-7-2015

Scientific and technical assistance on the evaluation of the temperature to be applied to pre-packed fishery products at retail level

European Food Safety Authority Relevant hazards associated with pre-packed fresh fishery products were identified through a literature search. The main temperature-dependent hazards identified are histamine formation, Listeria monocytogenes, Clostridium...

Europe - EFSA - European Food Safety Authority EFSA Journal

4-7-2015

Updating risk management recommendations to limit exposure of non-target Lepidoptera of conservation concern in protected habitats to Bt-maize pollen

EFSA Panel on Genetically Modified Organisms (GMO) Using mathematical modelling, the EFSA GMO Panel has previously quantified the risk to non-target (NT) Lepidoptera of conservation concern, potentially occurring within protected habitats, associated w...

Europe - EFSA - European Food Safety Authority EFSA Journal

4-7-2015

Scientific Opinion on the re-evaluation of oxidised polyethylene wax (E 914) as a food additive

EFSA Panel on Food Additives and Nutrient Sources added to food (ANS) The EFSA ANS Panel delivered a scientific opinion re-evaluating the safety of oxidised polyethylene wax (OPEW) (E 914) as a food additive. E 914 is authorised at quan...

Europe - EFSA - European Food Safety Authority EFSA Journal

6-7-2015

News and press releases: Improving safety of medicines across Europe

EMA publication of safety reports for nationally authorised medicines will support timely and harmonised implementation of safety measures in EU Member States...

Europe - EMA - European Medicines Agency

6-7-2015

LEVOCETIRIZINE DIHYDROCHLORIDE Tablet, Film Coated [Ranbaxy Pharmaceuticals Inc.]

Updated Date: Jul 6, 2015 EST...

US - DailyMed

6-7-2015

DEXAMETHASONE SODIUM PHOSPHATE Injection [General Injectables And Vaccines, Inc.]

Updated Date: Jul 6, 2015 EST...

US - DailyMed

6-7-2015

ALL DAY PAIN RELIEF (Naproxen Sodium) Tablet [CVS Pharmacy]

Updated Date: Jul 6, 2015 EST...

US - DailyMed